Lickfett L, Calkins H
Johns Hopkins Hospital, Baltimore, Maryland, USA.
Minerva Cardioangiol. 2002 Jun;50(3):189-207.
The clinical introduction of catheter ablation in 1981 revolutionized the treatment of cardiac arrhythmias. Implementation of radiofrequency as an alternative energy source, with the advantages of higher selectivity and less collateral damage, provided an expansion of catheter ablation therapy. Today the majority of arrhythmias can potentially be cured with catheter ablation therapy. The safety and efficacy of catheter ablation for treatment of AV nodal reentrant tachycardia, accessory pathway arrhythmias, focal atrial tachycardia, atrial flutter and idiopathic ventricular tachycardia, is well established. Catheter ablation for treatment of atrial fibrillation and ventricular tachycardia secondary to structural heart disease, remains an area of active research. In this article we will review the current state of knowledge about the technique, indications, and results of catheter ablation for the treatment of cardiac arrhythmias.
1981年导管消融术的临床应用彻底改变了心律失常的治疗方式。射频作为一种替代能源的应用,具有更高的选择性和更少的附带损伤等优点,使得导管消融治疗得到了扩展。如今,大多数心律失常都有可能通过导管消融治疗治愈。导管消融治疗房室结折返性心动过速、旁路心律失常、局灶性房性心动过速、心房扑动和特发性室性心动过速的安全性和有效性已得到充分证实。用于治疗心房颤动和继发于结构性心脏病的室性心动过速的导管消融术,仍然是一个活跃的研究领域。在本文中,我们将综述关于导管消融治疗心律失常的技术、适应证和结果的当前知识状态。